Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

A

AKTX

Akari Therapeutics Plc ADR

8.70

Jul 24 • 3:56 PM ET -0.60 (-6.45%)

8.60

Aftermarket • 5:25 PM ET -0.10 (-1.15%)

Healthcare Biotechnology USA Nano NASD

Peers: IKT NBP NERV NVCT ALXO BCYC CGEN FATE FHTX CDXS

Scroll to Statements

Index	-
Market Cap	9.92M
Enterprise Value	7.82M
Income	-28.00M
Sales	0.00M
Book/sh	12.56
Cash/sh	2.48
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	6
IPO	May 07, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.69
P/C	3.50
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.27
Current Ratio	0.27
Debt/Eq	0.05
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-18.86
EPS next Y	-2.56
EPS next Q	-1.04
EPS this Y	61.27%
EPS next Y	68.04%
EPS next 5Y	44.90%
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-75.83%
Sales Q/Q	-
Earnings	May 14
EPS/Sales Surpr.	-632.33% -

Insider Own	0.40%
Insider Trans	0.00%
Inst Own	14.02%
Inst Trans	50.13%
ROA	-66.00%
ROE	-155.01%
ROIC	-194.71%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-23.72%
SMA50	-25.57%
SMA200	-33.98%
Trades

Shs Outstand	1.14M
Shs Float	1.14M
Short Float	1.44%
Short Ratio	0.02
Short Interest	0.02M
52W High	49.60 -82.46%
52W Low	3.02 188.56%
Volatility	18.83% 17.28%
ATR (14)	1.82
RSI (14)	38.69
Beta	1.40
Rel Volume	0.04
Avg Volume	794.70K
Volume	28,115

Perf Week	-20.98%
Perf Month	-19.11%
Perf Quarter	45.00%
Perf Half Y	-18.96%
Perf YTD	-24.74%
Perf Year	-80.23%
Perf 3Y	-93.76%
Perf 5Y	-99.33%
Perf 10Y	-99.88%
Recom	1.00
Target Price	28.50
Prev Close	9.30
Price	8.70
Change	-6.45%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)